Adverse effects associated with treatment of dyslipidaemia/statin intolerance Statin intolerance is a phenomenon that has been observed for years, but the interest in it in recent years is associated with the introduction of new agents in combination therapy (PCSK9 inhibitors, inclisiran, and bempedoic acid) (Section 9.10)
A: Dihexa is an unregulated research chemical in many jurisdictions, meaning it has not been scheduled by the DEA or classified as a controlled substance
PMID: 31701550.
Contrary to this notion, a large cohort of more than 74,000 patients treated with spironolactone found no evidence of an increased risk of breast, ovarian, or endometrial cancer.[50] These results have been supported by several other recent studies that investigated the potential relationship between spironolactone and risk of hormonally dependent cancers.[51,52] All in all, spironolactone is a safe systemic medication to consider for healthy women seeking treatment for oily skin
If a patient becomes pregnant while receiving NAD+, the treatment would be discontinued unless there were extraordinary circumstances and a careful risk-benefit assessment by the healthcare provider
Tissue Repair Known for gut lining protection and enhanced wound healing, BPC-157 may apply similar repair mechanisms to the endometrium and other reproductive tissue